Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma
Condition:   Sarcoma, Soft Tissue Intervention:   Drug: DPPG2-TSL-DOX Sponsor:   Thermosome GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 15, 2023 Category: Research Source Type: clinical trials

The Combination of Radiotherapy ,Surufatinib and Sintilimab in High-Risk Localized Soft Tissue Sarcoma
Condition:   High-Risk Localized Soft Tissue Sarcoma Interventions:   Drug: Surufatinib;   Drug: Sintilimab;   Radiation: Radiotherapy Sponsor:   Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2023 Category: Research Source Type: clinical trials